Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors: A Systematic Review and Individual Participant Data Meta-Analysis

In this study, cancer outcomes in SOTRs receiving ICIs varied by cancer type, with a higher probability of achieving response among those with cSCC than other cancers. Concurrent use of mTORIs and steroids during ICI therapy may reduce the risk of acute allograft rejection.